Copyright Reports & Markets. All rights reserved.

Global Gene-based Advanced Therapy Medical Product Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Viral Gene Delivery System
    • 1.2.3 Non-viral Gene Delivery System
  • 1.3 Market by Application
    • 1.3.1 Global Gene-based Advanced Therapy Medical Product Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Neurological Diseases
    • 1.3.3 Cancer
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gene-based Advanced Therapy Medical Product Market Perspective (2016-2027)
  • 2.2 Gene-based Advanced Therapy Medical Product Growth Trends by Regions
    • 2.2.1 Gene-based Advanced Therapy Medical Product Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Gene-based Advanced Therapy Medical Product Historic Market Share by Regions (2016-2021)
    • 2.2.3 Gene-based Advanced Therapy Medical Product Forecasted Market Size by Regions (2022-2027)
  • 2.3 Gene-based Advanced Therapy Medical Product Industry Dynamic
    • 2.3.1 Gene-based Advanced Therapy Medical Product Market Trends
    • 2.3.2 Gene-based Advanced Therapy Medical Product Market Drivers
    • 2.3.3 Gene-based Advanced Therapy Medical Product Market Challenges
    • 2.3.4 Gene-based Advanced Therapy Medical Product Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gene-based Advanced Therapy Medical Product Players by Revenue
    • 3.1.1 Global Top Gene-based Advanced Therapy Medical Product Players by Revenue (2016-2021)
    • 3.1.2 Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Players (2016-2021)
  • 3.2 Global Gene-based Advanced Therapy Medical Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Gene-based Advanced Therapy Medical Product Revenue
  • 3.4 Global Gene-based Advanced Therapy Medical Product Market Concentration Ratio
    • 3.4.1 Global Gene-based Advanced Therapy Medical Product Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gene-based Advanced Therapy Medical Product Revenue in 2020
  • 3.5 Gene-based Advanced Therapy Medical Product Key Players Head office and Area Served
  • 3.6 Key Players Gene-based Advanced Therapy Medical Product Product Solution and Service
  • 3.7 Date of Enter into Gene-based Advanced Therapy Medical Product Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene-based Advanced Therapy Medical Product Breakdown Data by Type

  • 4.1 Global Gene-based Advanced Therapy Medical Product Historic Market Size by Type (2016-2021)
  • 4.2 Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Type (2022-2027)

5 Gene-based Advanced Therapy Medical Product Breakdown Data by Application

  • 5.1 Global Gene-based Advanced Therapy Medical Product Historic Market Size by Application (2016-2021)
  • 5.2 Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Gene-based Advanced Therapy Medical Product Market Size (2016-2027)
  • 6.2 North America Gene-based Advanced Therapy Medical Product Market Size by Type
    • 6.2.1 North America Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2021)
    • 6.2.2 North America Gene-based Advanced Therapy Medical Product Market Size by Type (2022-2027)
    • 6.2.3 North America Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2027)
  • 6.3 North America Gene-based Advanced Therapy Medical Product Market Size by Application
    • 6.3.1 North America Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2021)
    • 6.3.2 North America Gene-based Advanced Therapy Medical Product Market Size by Application (2022-2027)
    • 6.3.3 North America Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2027)
  • 6.4 North America Gene-based Advanced Therapy Medical Product Market Size by Country
    • 6.4.1 North America Gene-based Advanced Therapy Medical Product Market Size by Country (2016-2021)
    • 6.4.2 North America Gene-based Advanced Therapy Medical Product Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Gene-based Advanced Therapy Medical Product Market Size (2016-2027)
  • 7.2 Europe Gene-based Advanced Therapy Medical Product Market Size by Type
    • 7.2.1 Europe Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2021)
    • 7.2.2 Europe Gene-based Advanced Therapy Medical Product Market Size by Type (2022-2027)
    • 7.2.3 Europe Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2027)
  • 7.3 Europe Gene-based Advanced Therapy Medical Product Market Size by Application
    • 7.3.1 Europe Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2021)
    • 7.3.2 Europe Gene-based Advanced Therapy Medical Product Market Size by Application (2022-2027)
    • 7.3.3 Europe Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2027)
  • 7.4 Europe Gene-based Advanced Therapy Medical Product Market Size by Country
    • 7.4.1 Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2016-2021)
    • 7.4.2 Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size (2016-2027)
  • 8.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Type
    • 8.2.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Application
    • 8.3.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region
    • 8.4.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Gene-based Advanced Therapy Medical Product Market Size (2016-2027)
  • 9.2 Latin America Gene-based Advanced Therapy Medical Product Market Size by Type
    • 9.2.1 Latin America Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2021)
    • 9.2.2 Latin America Gene-based Advanced Therapy Medical Product Market Size by Type (2022-2027)
    • 9.2.3 Latin America Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2027)
  • 9.3 Latin America Gene-based Advanced Therapy Medical Product Market Size by Application
    • 9.3.1 Latin America Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2021)
    • 9.3.2 Latin America Gene-based Advanced Therapy Medical Product Market Size by Application (2022-2027)
    • 9.3.3 Latin America Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2027)
  • 9.4 Latin America Gene-based Advanced Therapy Medical Product Market Size by Country
    • 9.4.1 Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2016-2021)
    • 9.4.2 Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size (2016-2027)
  • 10.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Type
    • 10.2.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Application
    • 10.3.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country
    • 10.4.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Biogen
    • 11.1.1 Biogen Company Details
    • 11.1.2 Biogen Business Overview
    • 11.1.3 Biogen Gene-based Advanced Therapy Medical Product Introduction
    • 11.1.4 Biogen Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.1.5 Biogen Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Gene-based Advanced Therapy Medical Product Introduction
    • 11.2.4 Novartis Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.2.5 Novartis Recent Development
  • 11.3 Gilead Sciences
    • 11.3.1 Gilead Sciences Company Details
    • 11.3.2 Gilead Sciences Business Overview
    • 11.3.3 Gilead Sciences Gene-based Advanced Therapy Medical Product Introduction
    • 11.3.4 Gilead Sciences Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.3.5 Gilead Sciences Recent Development
  • 11.4 Sarepta Therapeutics
    • 11.4.1 Sarepta Therapeutics Company Details
    • 11.4.2 Sarepta Therapeutics Business Overview
    • 11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Introduction
    • 11.4.4 Sarepta Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.4.5 Sarepta Therapeutics Recent Development
  • 11.5 Alnylam Pharmaceuticals
    • 11.5.1 Alnylam Pharmaceuticals Company Details
    • 11.5.2 Alnylam Pharmaceuticals Business Overview
    • 11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Introduction
    • 11.5.4 Alnylam Pharmaceuticals Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.5.5 Alnylam Pharmaceuticals Recent Development
  • 11.6 Amgen
    • 11.6.1 Amgen Company Details
    • 11.6.2 Amgen Business Overview
    • 11.6.3 Amgen Gene-based Advanced Therapy Medical Product Introduction
    • 11.6.4 Amgen Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.6.5 Amgen Recent Development
  • 11.7 Spark Therapeutics
    • 11.7.1 Spark Therapeutics Company Details
    • 11.7.2 Spark Therapeutics Business Overview
    • 11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medical Product Introduction
    • 11.7.4 Spark Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.7.5 Spark Therapeutics Recent Development
  • 11.8 Akcea Therapeutics
    • 11.8.1 Akcea Therapeutics Company Details
    • 11.8.2 Akcea Therapeutics Business Overview
    • 11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Introduction
    • 11.8.4 Akcea Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.8.5 Akcea Therapeutics Recent Development
  • 11.9 bluebird bio
    • 11.9.1 bluebird bio Company Details
    • 11.9.2 bluebird bio Business Overview
    • 11.9.3 bluebird bio Gene-based Advanced Therapy Medical Product Introduction
    • 11.9.4 bluebird bio Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.9.5 bluebird bio Recent Development
  • 11.10 Sunway Biotech
    • 11.10.1 Sunway Biotech Company Details
    • 11.10.2 Sunway Biotech Business Overview
    • 11.10.3 Sunway Biotech Gene-based Advanced Therapy Medical Product Introduction
    • 11.10.4 Sunway Biotech Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.10.5 Sunway Biotech Recent Development
  • 11.11 SIBIONO
    • 11.11.1 SIBIONO Company Details
    • 11.11.2 SIBIONO Business Overview
    • 11.11.3 SIBIONO Gene-based Advanced Therapy Medical Product Introduction
    • 11.11.4 SIBIONO Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.11.5 SIBIONO Recent Development
  • 11.12 AnGes
    • 11.12.1 AnGes Company Details
    • 11.12.2 AnGes Business Overview
    • 11.12.3 AnGes Gene-based Advanced Therapy Medical Product Introduction
    • 11.12.4 AnGes Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.12.5 AnGes Recent Development
  • 11.13 Orchard Therapeutics
    • 11.13.1 Orchard Therapeutics Company Details
    • 11.13.2 Orchard Therapeutics Business Overview
    • 11.13.3 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Introduction
    • 11.13.4 Orchard Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.13.5 Orchard Therapeutics Recent Development
  • 11.14 Human Stem Cells Institute
    • 11.14.1 Human Stem Cells Institute Company Details
    • 11.14.2 Human Stem Cells Institute Business Overview
    • 11.14.3 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Introduction
    • 11.14.4 Human Stem Cells Institute Revenue in Gene-based Advanced Therapy Medical Product Business (2016-2021)
    • 11.14.5 Human Stem Cells Institute Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Gene-based Advanced Therapy Medical Product Scope and Market Size
    Gene-based Advanced Therapy Medical Product market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene-based Advanced Therapy Medical Product market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Viral Gene Delivery System
    Non-viral Gene Delivery System

    Segment by Application
    Neurological Diseases
    Cancer
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute

    Buy now